|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn880437602 |
003 |
OCoLC |
005 |
20231117044941.0 |
006 |
m o d |
007 |
cr un|---uuuua |
008 |
140507s2014 enkabdf ob 001 0 eng d |
040 |
|
|
|a GGVRL
|b eng
|e rda
|e pn
|c GGVRL
|d OCLCO
|d OCLCQ
|d OCLCF
|d YDXCP
|d EBLCP
|d OPELS
|d UKMGB
|d N$T
|d OCLCQ
|d N9V
|d OCLCQ
|d U3W
|d D6H
|d OCLCA
|d WYU
|d LQU
|d UHL
|d OCLCQ
|d S2H
|d OCLCO
|d REDDC
|d TUHNV
|d OCLCO
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|
016 |
7 |
|
|a 016628552
|2 Uk
|
019 |
|
|
|a 866444558
|a 955585176
|a 1105173103
|a 1105560410
|a 1112936604
|a 1162100175
|a 1229063398
|a 1232036232
|
020 |
|
|
|a 9780128005699
|q (electronic book)
|
020 |
|
|
|a 0128005696
|q (electronic book)
|
020 |
|
|
|a 0128000538
|
020 |
|
|
|a 9780128000533
|
020 |
|
|
|z 9780128000533
|
035 |
|
|
|a (OCoLC)880437602
|z (OCoLC)866444558
|z (OCoLC)955585176
|z (OCoLC)1105173103
|z (OCoLC)1105560410
|z (OCoLC)1112936604
|z (OCoLC)1162100175
|z (OCoLC)1229063398
|z (OCoLC)1232036232
|
050 |
|
4 |
|a K3636
|b .L49 2014
|
060 |
|
4 |
|a QV 33.1
|b L496 2013eb
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.19
|
100 |
1 |
|
|a Lezotre, Pierre-Louis,
|e author.
|
245 |
1 |
0 |
|a International cooperation, convergence and harmonization of pharmaceutical regulations :
|b a global perspective /
|c Pierre-Louis Lezotre, MS, PhD.
|
264 |
|
1 |
|a Oxford :
|b Academic Press,
|c 2014.
|
300 |
|
|
|a 1 online resource (xviii, 349 pages, 8 unnumbered pages of plates) :
|b illustrations (chiefly color), color maps
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Part I. State of play and review of major cooperation initiatives -- part II. Value and influencing factors of the cooperation, convergence, and harmonization in the pharmaceutical sector -- part III. Recommendations to support the next phase of international cooperation, convergence, and harmonization in the pharmaceutical domain.
|
520 |
|
|
|a Provides the current status of the complex and broad phenomenon of cooperation, convergence and harmonization in the pharmaceutical sector.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Pharmaceutical industry.
|
650 |
|
0 |
|a World health.
|
650 |
|
0 |
|a International cooperation.
|
650 |
1 |
2 |
|a Legislation, Drug
|0 (DNLM)D007880
|
650 |
|
2 |
|a Drug Industry
|0 (DNLM)D004345
|
650 |
2 |
2 |
|a Global Health
|0 (DNLM)D014943
|
650 |
2 |
2 |
|a International Cooperation
|0 (DNLM)D007391
|
650 |
|
6 |
|a Industrie pharmaceutique.
|0 (CaQQLa)201-0042410
|
650 |
|
6 |
|a Sant�e mondiale.
|0 (CaQQLa)201-0037312
|
650 |
|
6 |
|a Coop�eration internationale.
|0 (CaQQLa)201-0040112
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a World health
|2 fast
|0 (OCoLC)fst01181338
|
650 |
|
7 |
|a International cooperation
|2 fast
|0 (OCoLC)fst00976857
|
650 |
|
7 |
|a Pharmaceutical industry
|2 fast
|0 (OCoLC)fst01060129
|
776 |
0 |
8 |
|i Print version:
|a Lezotre, Pierre-Louis.
|t International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations : A Global Perspective.
|d Burlington : Elsevier Science, �2013
|z 9780128000533
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128000533
|z Texto completo
|